Elise Deluche

10PUBLICATIONS
36CO-AUTHORS
Cancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 27, 2025
A prospective trial for breast cancer diagnosis by canine odorology.

Anne Tardivon, Benoit Mesurolle, Sylvain Dureau

|Sep 04, 2025
Patritumab deruxtecan in HR+HER2- advanced breast cancer: a phase 2 trial.

Barbara Pistilli, Fernanda Mosele, Noemie Corcos

|Aug 26, 2025
Evaluation of end-of-Life chemotherapy: a medical and economic challenge revealed by a retrospective observational study.

Paul Agius, Sophie Léobon, Gaëlle Maillan

|Jul 24, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial.

Fernanda Mosele, Elise Deluche, Amelie Lusque

|Jul 06, 2023
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settings.

D Hequet, N Hajjaji, E Charafe-Jauffret

|May 26, 2023
Physician compliance with multidisciplinary tumor board recommendations for managing gynecological cancers.

Clara Naessens, Jerome Laloze, Sophie Leobon

Pageof 2

Frequent Collaborators

2 joint publications

Patricia Kannouche

2 joint publications

Fabrice André

2 joint publications

Nathalie Droin

2 joint publications

Sophie Leobon